Patent details

EP2812702 Title: Diagnosis and management of CD30-expressing cancers

Basic Information

Publication number:
EP2812702
PCT Application Number:
US2013025392
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137460382
PCT Publication Number:
WO2013119990
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Diagnosis and management of CD30-expressing cancers
French Title of Invention:
Diagnostic et prise en charge des cancers exprimant le CD30
German Title of Invention:
Diagnose und Management von CD30-exprimierenden Krebsarten
SPC Number:

Dates

Filing date:
08/02/2013
Grant date:
17/04/2019
EP Publication Date:
17/12/2014
PCT Publication Date:
15/08/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2019
EP B1 Publication Date:
17/04/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/02/2020
Expiration date:
08/02/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/04/2019
 
 

Name:
Seattle Genetics, Inc.
Address:
21823 30th Drive, S.E., Bothell, WA 98021, United States (US)

Inventor

1

Name:
ALBERTSON, Tina
Address:
United States (US)

2

Name:
SMITH, Maria, L
Address:
United States (US)

Priority

Priority Number:
201261597547 P
Priority Date:
10/02/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; G01N 33/574;

Publication

European Patent Bulletin

1

Issue number:
201916
Publication date:
17/04/2019
Description:
Grant (B1)

2

Issue number:
201920
Publication date:
15/05/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages